Actively Recruiting
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
Led by Amsterdam UMC, location VUmc · Updated on 2023-06-02
500
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multi-center, observational cohort study including patients with prior coronary artery bypass grafting (CABG) and ≥1 saphenous vein grafts (SVG) presenting with recurrent ischemic symptoms. Objective: to investigate the clinical outcomes in patients with prior CABG evaluated for bypass graft failure and progression of native coronary artery disease (CAD). Follow-up will be collected through national registry databases, electronic medical patient records and standardized telephonic assessment at 3 and 5 years follow-up.
CONDITIONS
Official Title
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prior coronary artery bypass grafting
- One or more saphenous vein grafts
- Recurrent angina symptoms
You will not qualify if you...
- Younger than 18 years or older than 90 years
- Cardiogenic shock
- Pregnancy
- Failure to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Amsterdam University Medical Centers, Department of Cardiology
Amsterdam, Netherlands, 1081 HV
Actively Recruiting
Research Team
P
Paul Knaapen, Professor
CONTACT
R
Ruben de Winter, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here